Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion type Assertion NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_head.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion description "[Propranolol (1 micromol/L), a beta blocker, completely prevented the effect of isoproterenol to persistently or transiently increase TDR and to induce TdP in the LQT1 and LQT2 models, but facilitated TdP in the LQT3 model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_provenance.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion evidence source_evidence_literature NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_provenance.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion SIO_000772 10688323 NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_provenance.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion wasDerivedFrom befree-20140225 NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_provenance.
- NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_assertion wasGeneratedBy ECO_0000203 NP866213.RAFG5D1r7YVelfY9oshkwvQIiguSolvX-BgbNAJRhvLU0130_provenance.